Apr 15 2008
Critical Path Thinking (Drug Discovery News)
 
Apr 07 2008
Immune Tolerance Institute Appoints Aaron B. Kantor Ph.D. Chief Scientific Officer
 
Apr 04 2008
New centre to find biomarkers for immune diseases (Labtechnologist.com)
 
 
 

Founded in partnership with the University of California, San Francisco, ITI is pioneering novel approaches to illuminating the underlying biology of immune-related disease and mechanisms of drug action with a goal to discover and develop novel high value biomarkers that more effectively guide new drug development and match patients with therapies that will provide them the greatest benefit.
 



ITI aims to create a new paradigm for mechanism-based drug development through which cutting-edge analytical technologies become integral to the clinical development process...
 
more...



Translating important basic discoveries into therapeutics that specifically modulate immunity - without disrupting it globally - have the potential to transform the lives of millions...
 
more...